Zomedica Corp.Long
ZOM reaching denouement in symmetrical triangle
ZOM is about to reach the endpoint of it's symmetrical triangle. ZOM has been in the news a lot recently with the Carole Baskin mention and it also has a heavily patented technology coming out at the end of March. This stock has a great leadership team as well. Do you own do dill but I think this one is going up! Price target is $2.50.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.